Ellsworth Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-8,176
Closed -$468K – 141
2022
Q1
$468K Buy
+8,176
New +$447K 0.17% 87

Other funds holding ATEX

Ellsworth Advisors's ATEX Position: Q2 2022 in Review

Ellsworth Advisors sold out of Anterix (ATEX) in Q2 2022, closing a stake of 8,176 shares — an estimated $468K sold.

Ellsworth Advisors first reported a position in ATEX in Q1 2022 and held it in 1 quarter. The position peaked at $468K in Q1 2022. 94 funds tracked by Wall St. Rank hold ATEX as of Q2 2022.

  • Ellsworth Advisors reported no remaining Anterix position as of Q2 2022 after selling out during the quarter.
  • Ellsworth Advisors sold 8,176 Anterix shares in Q2 2022, an estimated $468K.
  • Ellsworth Advisors first reported a position in Anterix in Q1 2022 and held it in 1 quarter.
  • Ellsworth Advisors's Anterix position peaked at $468K in Q1 2022.
  • 94 funds tracked by Wall St. Rank held Anterix as of Q2 2022.

Based on Ellsworth Advisors's 13F filing for Q2 2022, filed 25 Jul 2022.